Logo
Daily Brief
Following
Why
NP

Novartis Pharmaceuticals

Multinational pharmaceutical company

Appears in 2 stories

Stories

The Race to Protect 27 Million Americans from Accidental Food Allergen Exposure

The Race to Protect 27 Million Americans from Accidental Food Allergen Exposure

Competitor; developing oral BTK inhibitor for food allergy

Money Moves developing
The Gene Therapy Revolution: From Fatal Setback to Living Cures

The Gene Therapy Revolution: From Fatal Setback to Living Cures

Manufacturer of Kymriah, first FDA-approved CAR-T therapy

New Capabilities dormant